Sign in

Tessa Andermann

@gutamr.bsky.social
116 followers 187 following 3 posts

Infectious diseases physician and gut microbiome researcher at UNC Chapel Hill. Looking for postdoc in microbial genomics, see below! #AMR #Microbiome #IDsky #TxID

PostsRepliesMedia
Tessa Andermann @gutamr.bsky.social · 15/08/2026
Microbial genomics postdoc — Andermann Lab, UNC Chapel Hill. Genome assembly & annotation, resistance genes & mobile genetic elements, and comparative/phylogenetic analyses linking genotype to phenotype, in clinical Enterobacterales. NIH R01-funded. unc.peopleadmin.com/postings/323...
078
Reposted by Tessa Andermann
uncglobalhealth.bsky.social @uncglobalhealth.bsky.social · 02/05/2025
Ross M Boyce, MD, MSc, discusses the issues with incomplete testing of #tickborne diseases and the need for greater awareness of the illnesses in the US. @uncpublichealth.bsky.social @unchealth.bsky.social @uncdeptmedicine.bsky.social - Read more here: go.unc.edu/Bf97S
go.unc.edu
Study Reveals Low Completion Rates for Essential Testing in Ehrlichiosis and Spotted Fever Cases
Ross M Boyce, MD, MSc, discusses the diagnostic challenges and the need for greater awareness of tick-borne illnesses in the US, considering their potential severity.
001
Reposted by Tessa Andermann
William F Wright @wwrighid.bsky.social · 21/03/2025
#IDSky #MedSky #PharmSky @idsainfo.bsky.social @cidjournal.bsky.social @ofidjournal.bsky.social @sidpharm.bsky.social 🔥 Ceftriaxone MIC cutoff of 8 μg/ml is an excellent predictor of ESBL production; PPV and NPV approaching 100% and 99.5%, respectively. doi.org/10.1128/JCM.00716-14
doi.org
Determining the Optimal Ceftriaxone MIC for Triggering Extended-Spectrum β-Lactamase Confirmatory Testing | Journal of Clinical Microbiology
ABSTRACT As routine testing of clinical isolates for extended-spectrum β-lactamase (ESBL) production (screen plus phenotypic confirmatory testing) is no longer required by the Clinical and Laboratory ...
084
Reposted by Tessa Andermann
David van Duin @davidvanduin.bsky.social · 07/12/2024
Check out case report on transplant recipient with M. abscessus treated with phage therapy and double B-lactams. Incredible work by Hatfull and Kreiswirth labs. 🧪 #TxID #AMR #IDsky www.nature.com/articles/s41...
nature.com
Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection - Nature Communications
Cristinziano et al. report the use of bacteriophages and dual beta lactam antibiotics to treat a patient with a Mycobacterium abscessus sternal wound infection. One of the phages was epigenetically mo...
0437
Reposted by Tessa Andermann
David van Duin @davidvanduin.bsky.social · 12/12/2024
ICYMI, nice article by Ryan Shields et al. on cefiderocol resistance in CRAB. @jac-amr.bsky.social academic.oup.com/jacamr/artic... #AMR #IDsky
academic.oup.com
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections
AbstractBackground. Cefiderocol exhibits potent in vitro activity against carbapenem-resistant Acinetobacter baumannii (CRAb), but this activity has not co
0143
Reposted by Tessa Andermann
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 14/12/2024
CEFI-ID 🆕✨Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria #idsky www.journalofinfection.com/article/S016...
journalofinfection.com
Real-world multicentre study of cefiderocol treatment of immunocompromised patients with infections caused by multidrug-resistant Gram-negative bacteria: CEFI-ID
The increase in the population of immunocompromised patients due to advances in management of end-stage diseases and transplants poses challenges in treating infections caused by multi-drug resistant (MDR) pathogens. Cefiderocol (FDC), a siderophore cephalosporin, has shown efficacy against carbapenem-resistant Gram-negative bacteria.
063
Reposted by Tessa Andermann
David van Duin @davidvanduin.bsky.social · 02/01/2025
Dr. Tessa Andermann from UNC reports high rates of resistance in Enterobacterales derived from stem cell transplant recipients. #IDsky #AMR #TxID academic.oup.com/ofid/advance...
academic.oup.com
The Prevalence of Multidrug Resistance in Enterobacterales is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation
AbstractBackground. Antimicrobial resistance is a global public health emergency. Patients undergoing hematopoietic stem cell transplantation (HCT) are at
081
Tessa Andermann @gutamr.bsky.social · 28/01/2025
Thank you for the post! @davidvanduin.bsky.social
020
Reposted by Tessa Andermann
David van Duin @davidvanduin.bsky.social · 06/01/2025
Check out interesting report on carbapenemase-producing Enterobacter from the CRACKLE studies. #IDsky #AMR 🧪 pubmed.ncbi.nlm.nih.gov/39667036/
pubmed.ncbi.nlm.nih.gov
Molecular epidemiology and clinical characterization of carbapenemase-producing Enterobacter spp. from an international cohort - PubMed
Our findings demonstrated that E. xiangfangensis and E. hoffmannii are common species among international carbapenemase-producing Enterobacter spp., potentially linked to the clonal spread of a few pr...
052
Reposted by Tessa Andermann
Anita Williams @catanita.bsky.social · 02/12/2024
Volume 2 of the #AMR Starter Pack is here! go.bsky.app/EUY2FUJ Follow these amazing people along with those in Vol. 1 go.bsky.app/KkZfvrh And don't forget to pin the Antimicrobial Resistance feed to get all the AMR posts in one place bsky.app/profile/did:...
93622